Skip to main content
. Author manuscript; available in PMC: 2020 Apr 19.
Published in final edited form as: Gut. 2019 May 10;69(1):122–132. doi: 10.1136/gutjnl-2018-317424

Figure 5. Synergism of FAK inhibitor and Ruxolitinib/Stattic.

Figure 5

(A-D) Median effect analysis showing the interaction between FAKi and Ruxolitinib or Stattic in Panc-1 (A-B) or KP2 (C-D), analyzed using Compusyn software.

Data represent the combined mean ± s.e.m of three independent experiments each performed in duplicate. Horizontal dotted lines indicate the boundaries for each interaction classification.